Overview of Vaccine-Preventable Diseases

This overview defines vaccine-preventable diseases (VPDs) as a class, explains how they are grouped by causative agent and by immunization goal, and summarizes the population-level evidence that vaccination has reduced their burden. It serves as an entry point to the more detailed topics on viral and bacterial VPDs and on disease elimination and eradication.

Definition

A vaccine-preventable disease is a communicable disease for which a licensed, effective vaccine exists; the term encompasses the pathogen, the clinical disease it causes, and the program context in which vaccination is used to prevent it.

Scope

The topic covers the definition and classification of vaccine-preventable diseases, the core epidemiologic concepts used to describe their burden and control, and the kind of evidence — chiefly long-run surveillance comparing the pre- and post-vaccine eras — that documents the impact of immunization. It is descriptive and educational, not a schedule or a source of individual immunization advice.

Core questions

• What criteria define a disease as vaccine-preventable?
• How are vaccine-preventable diseases classified — by pathogen type and by immunization objective?
• What evidence demonstrates that vaccination has reduced their burden?
• Which epidemiologic concepts (coverage, herd immunity, surveillance) are central to describing them?

Key concepts

• Vaccine-preventable disease (VPD)
• Classification by pathogen (viral, bacterial)
• Classification by goal (control, elimination, eradication)
• Vaccination coverage
• Herd immunity
• Surveillance and reporting
• Pre- versus post-vaccine era comparison

Key theories

Herd immunity

Sufficient population immunity interrupts transmission and indirectly protects susceptible people; the required coverage rises with the pathogen's transmissibility.

Mechanisms

Vaccines prime adaptive immunity so that vaccinated individuals are less likely to become infected, to develop severe disease, or to transmit the pathogen. Aggregated across a population, this lowers transmission and, above a coverage threshold, can drive incidence to very low levels. Surveillance systems track reported cases against historical baselines, which is how the impact of immunization is quantified and how programs are evaluated.

Clinical relevance

A working knowledge of which diseases are vaccine-preventable and how their epidemiology has changed underpins public-health literacy and evidence appraisal. The documented declines describe the population effect of immunization programs and characterize evidence rather than direct individual care.

Epidemiology

Long-run comparisons in countries with established programs show that representative VPDs have declined by roughly 90 percent or more in reported cases relative to the pre-vaccine era, with parallel reductions in deaths and hospitalizations. The magnitude differs by disease and is contingent on sustained high coverage and functioning surveillance.

Evidence & guidelines

The principal evidence is observational and program-based: national and international surveillance data compared across vaccine eras, summarized in syntheses such as Roush and colleagues' analysis of U.S. morbidity and mortality. Disease-specific recommendations are issued by national immunization technical advisory groups and, internationally, in WHO vaccine position papers, which this entry references for orientation rather than as individualized guidance.

History

The category of vaccine-preventable disease expanded from smallpox through the twentieth-century development of vaccines against diphtheria, pertussis, tetanus, polio, measles, and many other agents. Coordinated immunization programs and surveillance from the 1970s onward made the population impact measurable and framed the goals of control, elimination, and eradication.

Key figures

• Stanley Plotkin
• Walter Orenstein
• Paul Fine

Seminal works

• roush-2007
• fine-1993
• plotkin-2018

Frequently asked questions

How are vaccine-preventable diseases usually classified?

Most commonly by the type of pathogen that causes them (for example, viral versus bacterial) and by the public-health goal of the vaccination program (control, elimination, or eradication).

How do we know vaccination reduced these diseases?

Chiefly through long-run surveillance that compares reported cases, hospitalizations, and deaths before and after a vaccine was introduced, which for many diseases shows declines of about 90 percent or more.